Sex | RF | ACPA | ACPA/RF | bDMARDs | ||||||||
All | Male | Female | Positive | Negative | Positive | Negative | Positive | Negative | Use | No use | ||
Cardiovascular risk age | 0.68 (0.03) | 0.7 (0.05) | 0.63 (0.05) | 0.68 (0.04) | 0.68 (0.08) | 0.72 (0.04) | 0.61 (0.06) | 0.71 (0.04) | 0.65 (0.1) | 0.78 (0.14) | 0.67 (0.03) | |
Vascular age [H-risk] | 0.71 (0.03) | 0.72 (0.05) | 0.67 (0.04) | 0.7 (0.04) | 0.77 (0.07) | 0.74 (0.04) | 0.67 (0.06) | 0.74 (0.04) | 0.75 (0.08) | 0.78 (0.14) | 0.71 (0.03) | |
Vascular age [L-risk] | 0.71 (0.03) | 0.72 (0.05) | 0.67 (0.04) | 0.7 (0.04) | 0.76 (0.07) | 0.74 (0.04) | 0.67 (0.06) | 0.73 (0.04) | 0.74 (0.08) | 0.8(0.14) | 0.71 (0.03) | |
Vascular age [HDLc H-risk | 0.71 (0.03) | 0.71 (0.05) | 0.68 (0.04) | 0.7 (0.03) | 0.78 (0.07) | 0.73 (0.04) | 0.69 (0.06) | 0.72 (0.04) | 0.77 (0.08) | 0.78 (0.14) | 0.71 (0.03) | |
Vascular age [HDLc L-risk] | 0.72 (0.03) | 0.72 (0.05) | 0.68 (0.04) | 0.7 (0.03) | 0.76 (0.07) | 0.74 (0.04) | 0.69 (0.06) | 0.73 (0.04) | 0.75 (0.08) | 0.79 (0.14) | 0.71 (0.03) | |
Glucocorticoids | DAS28 | RA disease duration | Methotrexate | sDMARDs | ||||||||
Use | No use | < 3.2 | ≥ 3.2 | ≤ 1 year | > 1 year | Use | No use | Use | No use | |||
Cardiovascular risk age | 0.57 (0.08) | 0.71 (0.04) | 0.6 (0.09) | 0.69 (0.04) | 0.69 (0.03) | 0.6 (0.08) | 0.67 (0.09) | 0.68 (0.03) | 0.62 (0.08) | 0.69 (0.03) | ||
Vascular age [H-risk] | 0.61 (0.08) | 0.74 (0.03) | 0.67 (0.09) | 0.72 (0.03) | 0.73 (0.03) | 0.63 (0.08) | 0.68 (0.09) | 0.72 (0.03) | 0.64 (0.08) | 0.73 (0.03) | ||
Vascular age [L-risk] | 0.59 (0.08) | 0.74 (0.03) | 0.67 (0.09) | 0.71 (0.03) | 0.73 (0.03) | 0.63 (0.08) | 0.7 (0.09) | 0.71 (0.03) | 0.65 (0.08) | 0.72 (0.03) | ||
Vascular age [HDLc H-risk | 0.6 (0.08) | 0.74 (0.03) | 0.66 (0.09) | 0.72 (0.03) | 0.73 (0.03) | 0.63 (0.08) | 0.69 (0.09) | 0.72 (0.03) | 0.65 (0.08) | 0.72 (0.03) | ||
Vascular age [HDLc Lrisk] | 0.62 (0.08) | 0.74 (0.03) | 0.67 (0.09) | 0.72 (0.03) | 0.73 (0.03) | 0.64 (0.08) | 0.71 (0.09) | 0.72 (0.03) | 0.66 (0.08) | 0.72 (0.03) |